Trademark: 86271626
Word
ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
Status
Registered
Status Code
701
Status Date
Thursday, November 10, 2022
Serial Number
86271626
Registration Number
4966469
Registration Date
Tuesday, May 24, 2016
Mark Type
4000
Filing Date
Monday, May 5, 2014

Trademark Owner History
M2GEN, CORP. -
Moffitt Genetics Corporation - Original Registrant

Classifications
41 Medical educational and training services, namely, conducting lectures, seminars, workshops, conferences, internships, fellowships, residencies, and workshops in the field of cancer
16 Publications, namely, printed materials, brochures, pamphlets, bulletins, newsletter and magazines in the field of cancer, bioinformatics and biotechnologies
44 Data collection for research purposes, namely, providing medical evaluations of patients to determine acceptability for participation in clinical trials; Providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of cancer; Healthcare services, namely, providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions
42 Medical, clinical, and scientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; Scientific and technological services, namely, collaborative scientific research and development services for researchers in the fields of oncology, namely, development of proprietary bioinformatic analysis software pipelines and computer systems for collecting, storing, characterizing, sorting, viewing, and delivering medical data and research information to clients; designing genomic experiments in context of client driven strategic goals; providing scientific research data, including custom, proprietary bioinformatic analysis of data generated in the fields of genomics and oncology; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples; Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific and technological services, namely, research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of bioinformatics and oncology; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online nondownloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting clinical studies and selecting patients for clinical studies in the field of cancer therapy for others; Conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research; technological and scientific data analysis in the field of oncology; scientific and research consulting services, namely, technical data collection, research analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; providing temporary use of non-downloadable scientific research and analysis software in the field of oncology and bioinformatics; Providing a website portal featuring bioinformatic research data and search engine for biomedical data for data mining and pattern recognition, selecting patients for clinical studies, designing clinical studies, and generating genomic data from patient samples in the field of oncology; providing temporary use of non-downloadable bioinformatic software for diagnosing medical conditions, preparing medical data, research and reports for data mining and pattern recognition, selecting patient for clinical studies, designing clinical studies, and generating genomic data from patient samples in the field of oncology; technical and scientific data analysis in the field of oncology
"INFORMATION EXCHANGE NETWORK"

Trademark Events
Nov 10, 2022
Notice Of Acceptance Of Sec. 8 - E-Mailed
Nov 10, 2022
Registered - Sec. 8 (6-Yr) Accepted
Nov 8, 2022
Teas Response To Office Action-Post Reg Received
May 25, 2022
Office Action Issued Pou1
May 25, 2022
Case Assigned To Post Registration Paralegal
May 10, 2022
Teas Section 8 Received
May 24, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 29, 2018
Automatic Update Of Assignment Of Ownership
May 24, 2016
Registered-Supplemental Register
Apr 15, 2016
Law Office Publication Review Completed
Apr 8, 2016
Approved For Registration Supplemental Register
Apr 8, 2016
Examiner's Amendment Entered
Apr 8, 2016
Notification Of Examiners Amendment E-Mailed
Apr 8, 2016
Examiners Amendment E-Mailed
Apr 8, 2016
Examiners Amendment -Written
Mar 29, 2016
Teas/Email Correspondence Entered
Mar 29, 2016
Correspondence Received In Law Office
Mar 18, 2016
Assigned To Lie
Mar 5, 2016
Teas Response To Office Action Received
Sep 16, 2015
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Sep 15, 2015
Notification Of Non-Final Action E-Mailed
Sep 15, 2015
Non-Final Action E-Mailed
Sep 15, 2015
Non-Final Action Written
Sep 15, 2015
Use Amendment Accepted
Sep 11, 2015
Teas/Email Correspondence Entered
Sep 10, 2015
Correspondence Received In Law Office
Sep 10, 2015
Teas Response To Office Action Received
Sep 11, 2015
Amendment To Use Processing Complete
Sep 11, 2015
Use Amendment Filed
Sep 10, 2015
Teas Amendment Of Use Received
Mar 11, 2015
Notification Of Non-Final Action E-Mailed
Mar 11, 2015
Non-Final Action E-Mailed
Mar 11, 2015
Non-Final Action Written
Mar 11, 2015
Notification Of Non-Final Action E-Mailed
Mar 11, 2015
Non-Final Action E-Mailed
Mar 11, 2015
Non-Final Action Written
Feb 23, 2015
Teas/Email Correspondence Entered
Feb 22, 2015
Correspondence Received In Law Office
Feb 22, 2015
Teas Response To Office Action Received
Aug 21, 2014
Notification Of Non-Final Action E-Mailed
Aug 21, 2014
Non-Final Action E-Mailed
Aug 21, 2014
Non-Final Action Written
Aug 19, 2014
Assigned To Examiner
Jun 5, 2014
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 5, 2014
Teas Change Of Owner Address Received
May 16, 2014
New Application Office Supplied Data Entered In Tram
May 8, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24